[DPHARMA] YoY Quarter Result on 30-Jun-2023 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
24-Aug-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2023
Quarter
30-Jun-2023 [#2]
Profit Trend
QoQ- -44.59%
YoY- -23.11%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 167,516 181,742 155,439 143,331 145,466 123,991 117,049 6.15%
PBT 16,515 21,473 20,197 19,391 18,316 12,915 12,642 4.55%
Tax -3,974 -5,162 -4,807 -4,662 -4,400 -2,576 -3,001 4.78%
NP 12,541 16,311 15,390 14,729 13,916 10,339 9,641 4.47%
-
NP to SH 12,541 16,311 15,390 14,729 13,916 10,339 9,653 4.45%
-
Tax Rate 24.06% 24.04% 23.80% 24.04% 24.02% 19.95% 23.74% -
Total Cost 154,975 165,431 140,049 128,602 131,550 113,652 107,408 6.29%
-
Net Worth 670,448 634,375 614,350 581,725 503,029 209,983 463,071 6.35%
Dividend
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Div 4,788 4,734 3,530 3,421 6,618 4,199 6,973 -6.07%
Div Payout % 38.19% 29.02% 22.94% 23.23% 47.56% 40.62% 72.25% -
Equity
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Net Worth 670,448 634,375 614,350 581,725 503,029 209,983 463,071 6.35%
NOSH 961,942 952,239 706,330 684,383 661,881 650,902 278,959 22.90%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin 7.49% 8.97% 9.90% 10.28% 9.57% 8.34% 8.24% -
ROE 1.87% 2.57% 2.51% 2.53% 2.77% 4.92% 2.08% -
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
RPS 17.49 19.19 22.01 20.94 21.98 44.29 41.96 -13.56%
EPS 1.31 1.72 2.18 2.15 2.07 1.59 3.46 -14.93%
DPS 0.50 0.50 0.50 0.50 1.00 1.50 2.50 -23.51%
NAPS 0.70 0.67 0.87 0.85 0.76 0.75 1.66 -13.39%
Adjusted Per Share Value based on latest NOSH - 961,942
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
RPS 17.41 18.89 16.16 14.90 15.12 12.89 12.17 6.14%
EPS 1.30 1.70 1.60 1.53 1.45 1.07 1.00 4.46%
DPS 0.50 0.49 0.37 0.36 0.69 0.44 0.72 -5.89%
NAPS 0.697 0.6595 0.6387 0.6047 0.5229 0.2183 0.4814 6.35%
Price Multiplier on Financial Quarter End Date
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Date 30/06/23 30/06/22 30/06/21 30/06/20 28/06/19 29/06/18 30/06/17 -
Price 1.30 1.20 3.03 1.62 1.37 1.30 2.25 -
P/RPS 7.43 6.25 13.77 7.74 6.23 2.94 5.36 5.59%
P/EPS 99.28 69.66 139.03 75.27 65.16 35.20 65.02 7.30%
EY 1.01 1.44 0.72 1.33 1.53 2.84 1.54 -6.78%
DY 0.38 0.42 0.17 0.31 0.73 1.15 1.11 -16.35%
P/NAPS 1.86 1.79 3.48 1.91 1.80 1.73 1.36 5.35%
Price Multiplier on Announcement Date
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Date 24/08/23 16/08/22 17/08/21 13/08/20 30/08/19 26/11/18 25/08/17 -
Price 1.19 1.34 2.49 3.15 1.41 1.08 2.03 -
P/RPS 6.80 6.98 11.31 15.04 6.42 2.44 4.84 5.82%
P/EPS 90.88 77.78 114.25 146.36 67.06 29.25 58.66 7.56%
EY 1.10 1.29 0.88 0.68 1.49 3.42 1.70 -6.99%
DY 0.42 0.37 0.20 0.16 0.71 1.39 1.23 -16.38%
P/NAPS 1.70 2.00 2.86 3.71 1.86 1.44 1.22 5.68%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment